000 01823 a2200529 4500
005 20250518034020.0
264 0 _c20200527
008 202005s 0 0 eng d
022 _a1460-2180
024 7 _a10.1093/carcin/bgz069
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLuo, Dingyuan
245 0 0 _aPhospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.
_h[electronic resource]
260 _bCarcinogenesis
_c12 2019
300 _a1480-1491 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBrain Neoplasms
_xmetabolism
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aFemale
650 0 4 _aGlioblastoma
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Nude
650 0 4 _aOrganophosphates
_xpharmacology
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aSTAT3 Transcription Factor
_xdrug effects
650 0 4 _aValproic Acid
_xanalogs & derivatives
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aFraga-Lauhirat, Magdalena
700 1 _aMillings, Jonathan
700 1 _aHo, Cristella
700 1 _aVillarreal, Emily M
700 1 _aFletchinger, Teresa C
700 1 _aBonfiglio, James V
700 1 _aMata, Leyda
700 1 _aNemesure, Matthew D
700 1 _aBartels, Lauren E
700 1 _aWang, Ruixue
700 1 _aRigas, Basil
700 1 _aMackenzie, Gerardo G
773 0 _tCarcinogenesis
_gvol. 40
_gno. 12
_gp. 1480-1491
856 4 0 _uhttps://doi.org/10.1093/carcin/bgz069
_zAvailable from publisher's website
999 _c29597574
_d29597574